CO may not be equal to variations of SV due to changes in heart rate (HR). We assumed that assessment of fluid responsiveness based on SV would provide more reliable information concerning the effect of fluid infusion than assessment of fluid responsiveness based on CO. After Institutional Review Board approval, we conducted a prospective, observational study, in which patients monitored by an oesophageal Doppler during general anaesthesia were included. Haemodynamic parameters [HR, mean arterial pressure (MAP)] and oesophageal Doppler indices (SV, CO, and DrespSV) were collected before and after volume expansion with 500 ml of crystalloid. Two definitions of responders were tested: .15% increase in SV and .15% increase in CO after volume expansion. Patients were classified into three groups: non-responders, responders according to SV and CO, and discordant group. An analysis of variance (ANOVA) analysis with the Bonferroni post hoc analysis was used. The Pearson rank method tested linear correlations. A receiver-operating characteristic curve was generated for DrespSV to predict either increase in CO or in SV.
Of the 138 patients included in this study, 64 (47%) increased their SV and CO by more than 15%, and 15 (12%) increased only their SV by more than 15%. Patients in the discordant group had a significantly higher baseline HR, with a ,10% increase in CO (Table 1) . Variation of CO with fluid expansion was correlated with variation of SV and HR (r¼0.78, P,0.001, r¼0.37, P,0.001, respectively). DrespSV presented a better ability to predict a .15% increase in SV than a .15% increase in CO [area under the curve of 0.89 (CI 95% 0.82-0.95, P,0.0001) and 0.77 (CI 95% 0.68-0.85, P,0.0001), respectively]. Using Oldham's method, DrespSV and SV variations in response to fluid expansion were not correlated.
Based on our results, a standardized fluid infusion gave different results according to the two definitions of fluid responsiveness. Some patients were not classified as CO responders because fluid infusion produced opposite effects on the two determinants of CO, as fluid expansion was sometimes associated with a significant decrease in HR resulting in a less marked increase in CO than the cut-off used to define fluid responsiveness. Baseline haemodynamic parameters and their variation in response to volume expansion differed between the responder and discordant groups (Table 1) . Our observations may reflect two types of haemodynamic response to volume expansion depending on the baseline cardiovascular equilibrium. Assuming that all patients had no modification of drug dosage during the study period, baseline haemodynamic parameters of the discordant group may reflect adaptation of cardiovascular system, rather than in responders. Because CO is a physiologically controlled parameter dependent on several factors, 3 CO variations in response to volume expansion must be interpreted in terms of the variations of its two determinants (HR and SV). In some cases, the absence of increase in CO in response to fluid infusion may not indicate the absence of effect. Monitoring SV may provide more reliable information concerning the effect of fluid infusion. It may be preferable to use a definition of fluid responsiveness based on SV variation in studies testing the ability of an indicator to predict fluid responsiveness.
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Editor-In a recently published article, 1 Dr Adams and colleagues review, among others, two of our studies addressing dexmedetomidine for sedation in critically ill patients. 2 3 While we agree with their overall conclusion that 'so far the evidence of advantages of dexmedetomidine in the ICU setting remains limited', we would like to address some of their criticism of our studies. Dr Adams and colleagues mention that we did not find statistically significant differences in sedation between midazolam and dexmedetomidine treatment groups. We believe that they have missed important aspects of our study design: 3 our main interest was to assess the effect of the sedative drugs on length of mechanical ventilation, with the prerequisite that dexmedetomidine is not inferior to midazolam (and propofol) in maintaining the target sedation. We therefore used two hierarchial co-primary endpoints-first, assessing non-inferiority, and then comparing the effect on duration of mechanical ventilation. Only if the non-inferiority was confirmed, could the effect on mechanical ventilation be assessed. Non-inferiority designs have not been used before in assessing any current sedative drugs: our design requesting proof of non-inferiority in maintaining sedation before testing the hypothesis of shorter mechanical ventilation should be considered more rigorous compared with the conventional designs showing 'no difference'. We also tested the secondary outcome variables with the prerequisite that dexmedetomidine sedation was non-inferior (or at least as good) as sedation with the standard drug-something that has not been shown for any prior sedative. Further, the authors state that 'The main problem with assessing the effectiveness of sedation is that most measurements are made from subjective scales and that only one 
